Cleidocranial dysplasia (CCD) is a rare genetic condition that affects the bones and teeth. In our study, we presented three cases of CCD, including one with a new mutation and two with a family history. Case 1 had a unique heterozygous frameshift mutation (NM_001015051,c.762del, p.(Ser256Valfs*2)), while Case 2 and her brother (Case 3) had a common pathogenic missense mutation (NM_001015051,c.674G, p.Arg225Gln), which was also found in their father. The mutation in Case 1 was not reported before. Interestingly, the symptoms in Case 1, with the new mutation, were less severe than the other cases and the previous reports.
GolanIBaumertUWagenerH, et al.Atypical expression of cleidocranial dysplasia: Clinical and molecular-genetic analysis. Orthod Craniofac Res. 2002;5(4):243‐249.
2.
GargRKAgrawalP. Clinical spectrum of cleidocranial dysplasia: A case report. Cases J. 2008;1(1):377. Published 2008 Dec 8.
3.
ZhangTWuJZhaoX, et al.Whole-exome sequencing identification of a novel splicing mutation of RUNX2 in a Chinese family with cleidocranial dysplasia. Arch Oral Biol. 2019;100:49‐56.
4.
MaDWangXGuoJZhangJCaiT. Identification of a novel mutation of RUNX2 in a family with supernumerary teeth and craniofacial dysplasia by whole-exome sequencing: A case report and literature review. Medicine (Baltimore). 2018;97(32):e11328.
5.
ÇamtosunEAkıncıADemiralETekedereliİSığırcıA. A case of cleidocranial dysplasia with a novel mutation and growth velocity gain with growth hormone treatment. J Clin Res Pediatr Endocrinol. 2019;11(3):301‐305.
6.
PengYJChenQYFuDJ, et al.A novel gene mutation of Runx2 in cleidocranial dysplasia. J Huazhong Univ Sci Technolog Med Sci. 2017;37(5):772‐776.
7.
HashmiJAAlmatrafiALatifMNasirABasitS. An 18 bps in-frame deletion mutation in RUNX2 gene is a population polymorphism rather than a pathogenic variant. Eur J Med Genet. 2019;62(2):124‐128.
8.
NebgenDWoodRSShapiroRD. Management of a mandibular fracture in a patient with cleidocranial dysplasia: Report of a case and review of the literature. J Oral Maxillofac Surg. 1991;49(4):405‐409.
9.
CooperSCFlaitzCMJohnstonDALeeBHechtJT. A natural history of cleidocranial dysplasia. Am J Med Genet. 2001;104(1):1‐6.
10.
BhatMALawayBAMantooSChoudryKKotwalSMirSA. Cleidocranial dysplasia: A rare cause of disproportionate severe short stature. Oman Med J. 2012;27(5):408‐410.
11.
MedinaOMuñozNMonerizC. Cleidocranial dysplasia: A case report. Rev Chil Pediatr.2017;88(4):517‐523.
TakakiNMoriJMatsuoSOsamuraTMichigamiT. Cleidocranial dysplasia with growth hormone deficiency: A case report. BMC Pediatr. 2020;20(1):19. Published 2020 Jan 16.
JirapinyoCDerajeVHuangGGueSAndersonPJMooreMH. Cleidocranial dysplasia: Management of the multiple craniofacial and skeletal anomalies. J Craniofac Surg. 2020;31(4):908‐911.
16.
EnomotoHFuruichiTZanmaA, et al.Runx2 deficiency in chondrocytes causes adipogenic changes in vitro. J Cell Sci. 2004;117(Pt 3):417‐425.
17.
LeeBThirunavukkarasuKZhouL, et al.Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet. 1997;16(3):307‐310.
18.
MundlosS. Cleidocranial dysplasia: Clinical and molecular genetics. J Med Genet. 1999;36(3):177‐182.
19.
ChenSSantosLWuY, et al.Altered gene expression in human cleidocranial dysplasia dental pulp cells. Arch Oral Biol. 2005;50(2):227‐236.
20.
YoshidaTKaneganeHOsatoM, et al.Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations. Am J Hum Genet. 2002;71(4):724‐738.
21.
ShibataAMachidaJYamaguchiS, et al.Characterisation of novel RUNX2 mutation with alanine tract expansion from Japanese cleidocranial dysplasia patient. Mutagenesis. 2016;31(1):61‐67.
